Temporal association between the influenza virus and respiratory syncytial virus (RSV): RSV as a predictor of seasonal influenza

被引:10
|
作者
Miguez, A. [1 ]
Iftimi, A. [2 ]
Montes, F. [2 ]
机构
[1] Publ Hlth Ctr Valencia, Dept Epidemiol, DGSP, Valencia, Spain
[2] Univ Valencia, Stat & Operat Res Dept, E-46100 Valencia, Spain
来源
EPIDEMIOLOGY AND INFECTION | 2016年 / 144卷 / 12期
关键词
ARMAX; influenza; logistic regression; RSV; SURVEILLANCE; DISEASE; INTERFERENCE; TIME;
D O I
10.1017/S095026881600090X
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Epidemiologists agree that there is a prevailing seasonality in the presentation of epidemic waves of respiratory syncytial virus (RSV) infections and influenza. The aim of this study is to quantify the potential relationship between the activity of RSV, with respect to the influenza virus, in order to use the RSV seasonal curve as a predictor of the evolution of an influenza virus epidemic wave. Two statistical tools, logistic regression and time series, are used for predicting the evolution of influenza. Both logistic models and time series of influenza consider RSV information from previous weeks. Data consist of influenza and confirmed RSV cases reported in Comunitat Valenciana (Spain) during the period from week 40 (2010) to week 8 (2014). Binomial logistic regression models used to predict the two states of influenza wave, basal or peak, result in a rate of correct classification higher than 92% with the validation set. When a finer three-states categorization is established, basal, increasing peak and decreasing peak, the multinomial logistic model performs well in 88% of cases of the validation set. The ARMAX model fits well for influenza waves and shows good performance for short-term forecasts up to 3 weeks. The seasonal evolution of influenza virus can be predicted a minimum of 4 weeks in advance using logistic models based on RSV. It would be necessary to study more inter-pandemic seasons to establish a stronger relationship between the epidemic waves of both viruses.
引用
下载
收藏
页码:2621 / 2632
页数:12
相关论文
共 50 条
  • [1] A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV
    Turner, Tiffany M.
    Jones, Les P.
    Tompkins, S. Mark
    Tripp, Ralph A.
    JOURNAL OF VIROLOGY, 2013, 87 (19) : 10792 - 10804
  • [2] Latitudinal Variations in Seasonal Activity of Influenza and Respiratory Syncytial Virus (RSV): A Global Comparative Review
    Bloom-Feshbach, Kimberly
    Alonso, Wladimir J.
    Charu, Vivek
    Tamerius, James
    Simonsen, Lone
    Miller, Mark A.
    Viboud, Cecile
    PLOS ONE, 2013, 8 (02):
  • [3] Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy
    Beeler, Judy A.
    Eichelberger, Maryna C.
    MICROBIAL PATHOGENESIS, 2013, 55 : 9 - 15
  • [4] RESPIRATORY SYNCYTIAL VIRUS (RSV) OR ROUS-SARCOMA VIRUS (RSV)
    LINDHARDT, BO
    CHEST, 1995, 108 (01) : 292 - 292
  • [5] Clinical Characteristics and Course of Infections by Influenza A and Respiratory Syncytial Virus (RSV) in Hospitalized Adults
    Ambrosch, Andreas
    Klinger, Alfons
    Luber, Doris
    Arp, Claudia
    Lepiorz, Marc
    Schroll, Stefan
    Klawonn, Frank
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (09) : E68 - E75
  • [6] The adult respiratory syncytial virus The Respiratory Syncytial Virus (RSV) in Adults
    Frenzen, F.
    Mueller, G.
    Frenzen, K.
    PNEUMOLOGIE, 2020, 74 (06): : 374 - 386
  • [7] Respiratory Syncytial Virus (RSV) Update
    Krilov, Leonard R.
    Roberts Jr, Norbert
    VIRUSES-BASEL, 2022, 14 (10):
  • [8] Pathobiology of Respiratory Syncytial Virus (RSV)
    Tripp, Ralph A.
    McNamara, Paul S.
    VACCINES, 2020, 8 (03)
  • [9] Recombinant Influenza Virus Carrying the Respiratory Syncytial Virus (RSV) F85-93 CTL Epitope Reduces RSV Replication in Mice
    De Baets, Sarah
    Schepens, Bert
    Sedeyn, Koen
    Schotsaert, Michael
    Roose, Kenny
    Bogaert, Pieter
    Fiers, Walter
    Saelens, Xavier
    JOURNAL OF VIROLOGY, 2013, 87 (06) : 3314 - 3323
  • [10] Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
    Tripp, Ralph A.
    Martin, David E.
    VIRUSES-BASEL, 2022, 14 (03):